MedTrace Logo

The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort

NCT03146793 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2017-05-10

No results posted yet for this study

Summary

The national drug safety agency authorizes nominatively the use of sodium thiosulfate in dialysis patients with calciphylaxis. To date, it is the largest global cohort (more 600 patients from 2012 to 2016). We wanted to study retrospectively the fate of these patients at 6 months including mortality. Early use improves effectiveness.

Conditions

  • Calciphylaxis
  • Renal Insufficiency, Chronic

Interventions

DRUG

Sodium Thiosulfate

25g intravenously 3 times per week

Sponsors & Collaborators

  • Centre Hospitalier St Esprit

    lead OTHER

Principal Investigators

  • Albert TRINH-DUC, MD · Centre Hospitalier St EPSRIT AGEN FRANCE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2017-12-31
Completion
2018-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03146793 on ClinicalTrials.gov